期刊文献+

促肝细胞生长素部分逆转巨噬细胞趋化因子和马兜铃酸Ⅰ诱导的人肾小管上皮细胞转分化

Hepatocyte growth-promoting factor partially reverses monocyte chemotatic protein-1-and aristolochic acidⅠ-induced epithelial-to-mesenchymal transition of human kidney epithelial cells
下载PDF
导出
摘要 目的观察促肝细胞生长素(hepatocyte growth-promoting factor,pHGF)对巨噬细胞趋化因子(monocyte chemo-tatic protein-1,MCP-1)协同马兜铃酸Ⅰ(aristolochic acidⅠ,AAⅠ)诱导的人肾小管上皮细胞(HKC)凋亡及上皮细胞-间质细胞转分化(epithelial-mesenchymal transition,EMT)的影响。方法体外培养的HKC随机分为:空白对照组、转分化模型组及不同浓度pHGF(0.15、1.5、15、150、1500ng/ml)处理组。转分化模型组采用MCP-1(0.1μg/ml)协同AAⅠ(10μg/ml)诱导HKC转分化模型;pHGF处理组采用不同浓度pHGF对转分化模型HKC进行处理;空白对照组常规培养。采用WST-8法和流式细胞术观察各组细胞增殖和凋亡情况;RT-PCR检测各组细胞α-SMA mRNA表达;免疫组化检测各组细胞α-SMA、TGF-β1、FN蛋白的表达。结果与空白对照组相比,转分化模型组、不同浓度pHGF处理组HKC细胞增殖抑制率,凋亡细胞所占比例,α-SMA mRNA表达均明显升高(P<0.01),提示转分化模型制备成功。与转分化模型组细胞相比,pHGF(150ng/ml)处理组HKC增殖抑制率明显降低(P<0.01),各浓度pHGF处理组HKC凋亡细胞所占比例均明显降低(P<0.01),HKC细胞α-SMA mRNA表达下调(150ng/ml pHGF处理组尤明显);α-SMA、TGF-β1、FN蛋白表达下调。结论pHGF(150ng/ml)可部分逆转MCP-1协同AAⅠ诱导的HKC增殖抑制、凋亡和EMT。 Objective To observe the influence of hepatocyte growth-promoting factor ( pHGF) on monocyte chemotatic protein-1-(MCP-1) and aristolochic acid Ⅰ( AAⅠ)-induced epithelial-to-mesenchymal transition (EMT) and apoptosis of human kidney epithelial cell line( HKC). Methods The HKC cells were randomly divided into blank control group ( control groups) ,epithelial-to-mesenchymal transition model group ( model group) ,and pHGF inhibition group ( pHGF groups) with pHGF at different concentrations ( 0. 15,1. 5,15,150,and 1 500 ng/ml). The EMT model was established by exposing HKC cells to MCP -1( 0. 1 μg/ ml) and AAⅠ( 10 μg/ml). Cells in the pHGF groups were the model cells treated with different concentrations of pHGF. Cells in the control group were cultured routinely. WST -8 method and flow cytometry were used to observe the proliferation and apoptosis of HKC cells,respectively. The mRNA expression of α -smooth muscle actin( α-SMA) was determined by reverse transcriptase-polymerase chain reaction( RT-PCR) ,and the expression of α-SMA,fibronectin ( FN) ,and transforming growth factor-β1( TGF-β1) in HKC cells were assessed by indirect enzyme immunohistochemistry. Results The cell inhibitory rate,apoptotic rate,and expression of α-SMA mRNA were significantly increased in the model group and pHGF groups compared with those in the control group ( P 〈 0. 01) ,indicating the successful establishment of EMT model. Compared with the model group,pHGF at 150 ng/ml,but not at other concentrations,significantly decreased the inhibition rate of HKC cells( P 〈 0. 01). The apoptotic rate of HKC cells in all the pHGF groups were significantly lower than that in the model group ( P 〈 0. 01). pHGF at 150 ng/ml also greatly decreased the expression of α -SMA mRNA,and significantly down-regulated the expression of α-SMA,TGF-β1,and FN protein. Conclusion pHGF at 150 ng/ml can partly reverse MCP-1-and AA Ⅰ-induced HKC cell growth inhibition,apoptosis,and EMT.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2010年第1期51-54,共4页 Academic Journal of Second Military Medical University
基金 广州市科技计划项目(2002J1-C0361) 广东省医学科研基金(A2002349)~~
关键词 促肝细胞生长素 肾小管上皮细胞 细胞凋亡 上皮-间质细胞转分化 hepatocyte growth-promoting factor kidney epithelial cells apoptosis epithelial-to-mesenchymal transition
  • 相关文献

参考文献16

  • 1张宜俊,陈光明,孔祥平,郑国池,杨富强,胡肇椿.肝细胞生长素的研制及临床应用[J].临床肝胆病杂志,1991,7(1):15-19. 被引量:123
  • 2LaBrecque D R. Hepatic stimulator substance. Discovery, characteristics and mechanism of action[J]. Dig Dis Sci, 1991,36 : 669-673.
  • 3张宜俊,孔祥平,郑国池,陈光明,杨富强.促肝细胞生长素治疗慢性病毒性肝炎1668例疗效观察[J].临床肝胆病杂志,1995,11(3):137-140. 被引量:51
  • 4Zhang Y, Kong X, Zheng G. Chen G, Yang E. Evaluation of hepatocyte growth-promoting factors in treating 1687 cases of fulminant hepatitis[J]. Chin Med J ( Engl), 1995,108:928-929.
  • 5Liu X L, Sato S, Dai W, Yamanaka N. The protective effect of hepatocyte growth-promoting factor (pHGF) against hydrogen peroxide-induced acute lung injury in rats[J]. Med Electron Microsc. 2001,34:92-102,.
  • 6Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications[J]. Clin Chim Acta, 2003,327 (1-2) : 1-23.
  • 7Mou S,Wang Q, Shi B,Gu I.,Ni Z. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type Ⅲ collagen in human primary renal fibroblasts[J]. Kaohsiung J Med Sei, 2009,25: 577-587.
  • 8Tanaka H, Nagaike K, Takeda N, hoh H, Kohama K, Fukushima T, et al. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta[J]. Mol Cell Biol, 2005,25 :5687-5698.
  • 9Franquesa M,Riera M, Herrero-Fresneda I, Sola A, Hotter G. Lloberas N,et al. Tubular epithelial cells transfected with hHGF counteracts monocyte chemotactic protein-1 up-regulation after hypoxia/reoxygenation insult[J]. Transplant Proc, 2009, 41,2069-2072.
  • 10刘欣颖,罗海,王宓,陈辉珍,苏白海,李孜,许国章,樊均明.肝细胞生长因子对IL-1α刺激肾小管上皮细胞肌纤维母细胞转分化的作用[J].四川大学学报(医学版),2005,36(1):9-12. 被引量:6

二级参考文献52

  • 1曹丹,张玲.β-转化生长因子与肝细胞生长因子在肾间质纤维化中的关系[J].生命的化学,2006,26(2):152-154. 被引量:4
  • 2Klahr S.New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy[J].Am J Kidney Dis,1991,18:689-699.
  • 3Phanish MK,Wahab NA,Colville-Nash P.The differential role of Smad2 and Smad3 in the regulation of profibrotic TGF β1 responses in human proximal-tubule epithelial cells[J].Biochem J,2006,393(Pt 2):601-607.
  • 4Dai C and Liu Y.Hepatocyte growth factor antagonizes the profibrotic action of TGF-β 1 in masangial cells by stabilizing Smad transcriptional corepressor TGIF[J].J Am Soc Nephrol,2002,15:258-262.
  • 5Gong R,Rifai A,Tolbert EM.Hepatocyte growth factor modulates matrix metalloproteinases and plasminogenactive/plasmin proteolytic pathways in progressive renal interstitial fibrosis[J].J Am Sac Nephrol,2003,14:3047-3060.
  • 6Liu Y,Rajur K,Tolbert E.Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways[J].Kidney Int,2000,58:2028-2043.
  • 7SATO S,DAI Wei,Liu XL.The protective effect of Hepatocyte growth-promoting factor(p-HGF) agaist carbon tetrachlobridinduced acute live injury in rats,an ultrastructttral study[J].Med Electron Microse,1999,32:184-192.
  • 8Mizuno S, Kurosawa T, Matsumoto K, et al. Hepatocyte growth factor prevents renal fibrosis and dysfuction in a mouse model of chronic renal disease. J Clin Invest,1998;101(9): 1827.
  • 9Fan JM, Ng YY, Hill PA, et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int,1999;56(4):1455.
  • 10Fan JM, Huang XR, Ng YY, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis,2001;37(4):820.

共引文献235

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部